Abstract:Oxytocin has garnered much interest due to its role in affective states, social behaviors, and diverse physiological functions. However, approaches for measuring endogenous oxytocin concentrations have generated considerable controversy and debate. Common procedures for measuring oxytocin often produce uncorrelated results, and the detected concentrations frequently vary across two orders of magnitude. These findings have led some researchers to argue that immunoassays of plasma oxytocin may be unreliable and nonspecific, particularly when samples are not first processed using an extraction procedure. Here, we assess the specificity of oxytocin immunoassays using plasma samples from wildtype (WT) and oxytocin knockout (KO) mice. Plasma samples from both genotypes were measured using immunoassay and were measured with or without a solid phase extraction. Using a commercially available kit from Arbor Assays, we demonstrate that both techniques generate a clear contrast between genotypes, with wildtype samples containing high concentrations of oxytocin (unextracted mean = 468 pg/ml; extracted mean = 381 pg/ml), while knockout samples measured below the lower limit of detection. Analytical validations demonstrated good parallelism and spike recovery for both methods. Furthermore, the same wildtype samples measured with both procedures were highly correlated (r = 0.950), although unextracted samples measured at significantly higher concentrations (p = 2.0 ×10-7, Cohen's d = 2.65). To test the generalizability of these results across immunoassay kits, we performed additional assays with kits from Cayman Chemical and Enzo Life Sciences. The Cayman Chemical kit produced results similar to Arbor Assays with a clean signal differentiating WT and KO plasma, both with and without an extraction step. The Enzo kit also differentiated the genotypes, with correlation between extracted and unextracted samples, but was considerably more susceptible to interference without the extraction, as evidenced by false positive signal in KO plasma samples. The extent to which these results generalize to other species remains unknown and challenging to assess.

Validation of a newly generated oxytocin antibody for enzyme-linked immunosorbent assays

In need of a specific antibody against the oxytocin receptor for neuropsychiatric research: A KO validation study

Specificity of plasma oxytocin immunoassays: A comparison of commercial assays and sample preparation techniques using oxytocin knockout and wildtype mice

Synthesis and Identification of Ochratoxin A Artificial Immunogen

Establishment of Hybridoma Cell Lines Secreting High-titred Monoclonal Antibodies to Oxytocin

Neurophysin I is an Analytically Robust Surrogate Biomarker for Oxytocin

Development of ELISA and Lateral Flow Immunoassays for Ochratoxins (OTA and OTB) Detection Based on Monoclonal Antibody

Development of a Bridging ELISA for Detection of Antibodies Against ZV0203 in Cynomolgus Monkey Serum.

Development of a monoclonal antibody sandwich ELISA for the quality control of human and animal tetanus vaccines

Study on Competitive Enzyme-linked Immunosorbent Assay for Ochratoxin A Monoclonal Antibody Determination

Structurally related peptide impurity identification and accurate quantification for synthetic oxytocin by liquid chromatography-high-resolution mass spectrometry

Development of tetravalent antibody-enzyme complexes employing a lactate oxidase and the application to electrochemical immunosensors

Rapid generation of high-quality recombinant antibodies using an Expi293F expression system for a 17 β-estradiol immunoassay

Identification of a high-affinity monoclonal antibody against ochratoxin A and its application in enzyme-linked immunosorbent assay

Mass balance method for SI-traceable purity assignment of synthetic oxytocin

[Preparation and Application of Anti-Ouabain IgY Antibody].

Preparation of monoclonal antibody against orchratoxin A and establishment of ELISA to detect it

Preparation and Immunological Characterization of Monoclonal Antibody Against Ochratoxin A

Haptens Design and Production of Antibodies Against Toosendanin

Development of A New Rabbit Monoclonal Antibody and Its Based Competitive Indirect Enzyme-Linked Immunosorbent Assay for Rapid Detection of Sulfonamides

Establishment of Reverse Direct Elisa and Its Application in Screening High-Affinity Monoclonal Antibodies